New Results

Driving potent neutralization of a SARS-CoV-2 Variant of Concern with a heterotypic boost

Daniel J. Sheward, Marco Mandolesi, Changil Kim, Leo Hanke, Laura Perez Vidakovics, Gerald McInerney, Gunilla B. Karlsson Hedestam, Ben Murrell
doi: https://doi.org/10.1101/2021.04.03.438330

Article Information

doi 
https://doi.org/10.1101/2021.04.03.438330
History 
  • April 5, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Daniel J. Sheward*,✉,
  2. Marco Mandolesi1,*,
  3. Changil Kim1,
  4. Leo Hanke1,
  5. Laura Perez Vidakovics1,
  6. Gerald McInerney1,
  7. Gunilla B. Karlsson Hedestam1,†✉ and
  8. Ben Murrell1,†✉
  1. 1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
  1. ↵✉Correspondence:
    daniel.sheward{at}ki.se, gunilla.karlsson.hedestam{at}ki.se, benjamin.murrell{at}ki.se

  1. ↵* These authors contributed equally

  2. ↵† These authors contributed equally

Back to top
Posted April 05, 2021.
Download PDF
Email
Driving potent neutralization of a SARS-CoV-2 Variant of Concern with a heterotypic boost
Daniel J. Sheward, Marco Mandolesi, Changil Kim, Leo Hanke, Laura Perez Vidakovics, Gerald McInerney, Gunilla B. Karlsson Hedestam, Ben Murrell
bioRxiv 2021.04.03.438330; doi: https://doi.org/10.1101/2021.04.03.438330
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area